Brochures

Brochures

Global leader in Biomarker & Bioanalysis

Synexa Life Sciences has been a pioneer in the biomarker field for nearly 20 years.

August 10, 2022

ProtoTrials®

ProtoTrials® is a proprietary human in vitro translational immunology platform.

August 10, 2022

Bioanalytical Solutions for Immuno-oncology Therapeutics

Our speciality in immunology and immune-based analysis puts us at the forefront of driving immunotherapy development.

August 10, 2022

Measurement of phosphorylated SMAD-2/3

In fibrotic disease, deposition of extracellular matrix (ECM) proteins is increased. This compromises tissue architecture and interferes with normal organ function.

March 23, 2021

COVID-19: Biomarker Analysis

Synexa provides a large portfolio of biomarkers for COVID-19 therapeutic and vaccine development.

March 23, 2021

News Signup

"*" indicates required fields

Consent*
This field is for validation purposes and should be left unchanged.

Talk to our Biomarker Experts